{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T00:48:08Z","timestamp":1760921288970,"version":"build-2065373602"},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,19]]},"DOI":"10.7759\/cureus.94928","type":"journal-article","created":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:04:19Z","timestamp":1760897059000},"source":"Crossref","is-referenced-by-count":0,"title":["Rapid Clinical Recovery in Streptococcal Toxic Shock Syndrome With Intravenous Immunoglobulin (IVIG): A Case Report"],"prefix":"10.7759","author":[{"given":"Suhad","family":"Jalodi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad","family":"Naseem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Syed","family":"Abubacker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aima","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aymen","family":"Rasool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw248","article-title":"Epidemiology of invasive group A streptococcal infections in the United States, 2005-2012","volume":"63","author":"Nelson GE","year":"2016","unstructured":"Nelson GE, Pondo T, Toews KA, et al.. Epidemiology of invasive group A streptococcal infections in the United States, 2005-2012. Clin Infect Dis. 2016, 63:478-86. 10.1093\/cid\/ciw248","journal-title":"Clin Infect Dis"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1086\/521264","article-title":"The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004","volume":"45","author":"O'Loughlin RE","year":"2007","unstructured":"O'Loughlin RE, Roberson A, Cieslak PR, et al.. The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004. Clin Infect Dis. 2007, 45:853-62. 10.1086\/521264","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(05)70267-X","article-title":"The global burden of group A streptococcal diseases","volume":"5","author":"Carapetis JR","year":"2005","unstructured":"Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005, 5:685-94. 10.1016\/S1473-3099(05)70267-X","journal-title":"Lancet Infect Dis"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.51.1.271","article-title":"Streptococcal toxic shock syndrome associated with necrotizing fasciitis","volume":"51","author":"Stevens DL","year":"2000","unstructured":"Stevens DL. Streptococcal toxic shock syndrome associated with necrotizing fasciitis. Annu Rev Med. 2000, 51:271-88. 10.1146\/annurev.med.51.1.271","journal-title":"Annu Rev Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000100851","article-title":"Streptococcal superantigens","volume":"93","author":"Proft T","year":"2007","unstructured":"Proft T, Fraser JD. Streptococcal superantigens. Chem Immunol Allergy. 2007, 93:1-23. 10.1159\/000100851","journal-title":"Chem Immunol Allergy"},{"key":"ref6","unstructured":"Clinical guidance for streptococcal toxic shock syndrome. (2025). Accessed. 2025: https:\/\/www.cdc.gov\/group-a-strep\/hcp\/clinical-guidance\/streptococcal-toxic-shock-syndrome.html."},{"key":"ref7","article-title":"Polyspecific intravenous immunoglobulin in clindamycin-treated patients with streptococcal toxic shock syndrome: a systematic review and meta-analysis","volume":"67","author":"Ambrosioni J","year":"2018","unstructured":"Ambrosioni J, Urra X, Llopis J, Moreno A, Chamorro A, Mir\u00f3 JM. Polyspecific intravenous immunoglobulin in clindamycin-treated patients with streptococcal toxic shock syndrome: a systematic review and meta-analysis. Clin Infect Dis. 2018, 67:1146-7.","journal-title":"Clin Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1086\/376630","article-title":"Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial","volume":"37","author":"Darenberg J","year":"2003","unstructured":"Darenberg J, Ihendyane N, Sj\u00f6lin J, et al.. Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial. Clin Infect Dis. 2003, 37:333-40. 10.1086\/376630","journal-title":"Clin Infect Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1086\/515199","article-title":"Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study","volume":"28","author":"Kaul R","year":"1999","unstructured":"Kaul R, McGeer A, Norrby-Teglund A, et al.. Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome-a comparative observational study. Clin Infect Dis. 1999, 28:800-7. 10.1086\/515199","journal-title":"Clin Infect Dis"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1128\/iai.64.12.5395-5398.1996","article-title":"Evidence for the presence of streptococcal-superantigen-neutralizing antibodies in normal polyspecific immunoglobulin G","volume":"64","author":"Norrby-Teglund A","year":"1996","unstructured":"Norrby-Teglund A, Kaul R, Low DE, McGeer A, Andersson J, Andersson U, Kotb M. Evidence for the presence of streptococcal-superantigen-neutralizing antibodies in normal polyspecific immunoglobulin G. Infect Immun. 1996, 64:5395-8. 10.1128\/iai.64.12.5395-5398.1996","journal-title":"Infect Immun"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiac.2023.06.015","article-title":"Clinical outcomes and epidemiological characteristics of bacteremia in the older Japanese population","volume":"29","author":"Nakamura K","year":"2023","unstructured":"Nakamura K, Hayakawa K, Tsuzuki S, et al.. Clinical outcomes and epidemiological characteristics of bacteremia in the older Japanese population. J Infect Chemother. 2023, 29:971-7. 10.1016\/j.jiac.2023.06.015","journal-title":"J Infect Chemother"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/380304-rapid-clinical-recovery-in-streptococcal-toxic-shock-syndrome-with-intravenous-immunoglobulin-ivig-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:04:20Z","timestamp":1760897060000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/380304-rapid-clinical-recovery-in-streptococcal-toxic-shock-syndrome-with-intravenous-immunoglobulin-ivig-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,19]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.94928","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,19]]}}}